Clinical Trial Update: Personalized TCR-T: Study of Adoptively Transferred T-cell Receptor Gene-engineered T Cells (TCR-T) [Phase 1]

View source ↗

Summary

Phase 1 study of adoptively transferred T-cell receptor gene-engineered T cells (TCR-T) for malignant epithelial neoplasms is currently active but not recruitin…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer

Drugs mentioned

• TCR-T therapy (TCR-engineered T cells)

Snippet

Sponsor: Providence Health & Services | Conditions: Malignant Epithelial Neoplasms | Phase 1 | Status: ACTIVE_NOT_RECRUITING